QUOTE
Abbott Labs (ABT)
$
54.87
 -0.36 (-0.65%) Jan 26
|
100 Abbott Park Road
,
Abbott Park,
IL
60064
,
USA
+1-847-937-6100
http://www.abbott.com/ |
|
|
| PRICES |
| Open |
Volume |
| 55.44 |
7.28M |
| High |
Low |
| 55.45 |
54.73 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 84883 |
2.83M |
| 52wk High |
52wk Low |
| 56.72 |
45.16 |
|
| RATIOS |
| P/E |
EPS |
| 18.23 |
3.01 |
| BV |
P/BV |
| 14.47 |
3.79 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| 1.88 |
3.43% |
| Shares |
Inst Owner |
| 1546.98 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
| Income statement |
| Total Revenue |
$17,280.33 | $19,680.02 | $22,337.81 | $22,476.32 | $25,914.24 | $29,527.55 | $30,764.71 | $35,166.72 |
| Oprating Income |
$2,974.01 | $3,898.32 | $4,362.27 | $2,042.22 | $4,578.55 | $5,693.84 | $7,319.74 | $6,087.58 |
| Net Income |
$2,753.23 | $3,235.85 | $3,372.07 | $1,716.76 | $3,606.31 | $5,745.84 | $5,745.84 | $4,626.17 |
| Balance Sheet |
| Total Assets |
$26,039.31 | $28,767.49 | $29,141.20 | $36,178.17 | $39,713.92 | $42,419.20 | $52,416.62 | $59,462.27 |
| Total Equity |
$13,072.26 | $14,325.78 | $14,415.27 | $14,054.19 | $17,778.54 | $17,479.55 | $22,855.63 | $22,388.13 |
| Total Liabilities |
$12,967.05 | $14,441.71 | $14,725.93 | $22,123.99 | $21,935.38 | $24,939.65 | $29,561 | $37,074.13 |
| Cash Flow |
| Oprating |
$3,746.52 | $5,107.94 | $5,174.42 | $5,329.24 | $5,183.84 | $7,344.19 | $7,275.16 | $8,735.98 |
| Investing |
$-1,630.61 | $-3,923.39 | $-720.09 | $-11,397.63 | $-1,136.28 | $-2,087.49 | $-3,698.71 | $-12,188.32 |
| Financing |
$-2,006.21 | $-1,138.32 | $-2,592.32 | $3,621.93 | $-2,312.63 | $-3,485.90 | $1,002.02 | $-1,087.74 |
| Net Cash Change |
$290.67 | $230.50 | $1,668.06 | $-2,372.49 | $1,935.19 | $1,655.64 | $4,697.32 | $-5,160.97 |
|
Earning Call Calender
|
| 2009 | 2008 |
2007 |
2006 |
|
21 January 2009
15 April 2009
15 July 2009
14 October 2009
|
23 January 2008
16 April 2008
16 July 2008
15 October 2008
|
18 April 2007
18 July 2007
17 October 2007
|
25 January 2006
19 April 2006
19 July 2006
18 October 2006
| |
|
| Earning Call Summary |
Transcripts |
| |
|
Management
|
|
Executive |
Title |
|
Miles D. White |
Chairman of the Board, Chief Executive Officer | |
|
Thomas C. Freyman |
Chief Financial Officer, Executive Vice President-Finance |
|
Laura J. Schumacher |
Executive Vice President, General Counsel, Secretary |
|
Richard W. Ashley |
Executive Vice President - Corporate Development |
|
Edward L. Michael |
Executive Vice President, Diagnostics |
|
Holger A. Liepmann |
Executive Vice President - Global Nutrition |
|
John M. Capek, Ph.D. |
Executive Vice President, Medical Devices |
|
Stephen R. Fussell |
Senior Vice President - Human Resources |
|
Olivier Bohuon |
Executive Vice President, Pharmaceutical Products |
|
John C. Landgraf |
Senior Vice President, Global Pharmaceutical Manufacturing and Supply |
|
John M. Leonard, M.D. |
Senior Vice President, Pharmaceuticals, Research and Development |
|
Donald V. Patton |
Senior Vice President, U.S. Pharmaceuticals |
|
Mary Szela |
Senior Vice President, Global Strategic Marketing and Services |
|
|
|
